Posts Tagged ‘Càncer’

Wednesday October 15th, 2014

A combined therapy improves survival in patients with metastatic melanoma

According to an international multicenter study published in the New England Journal of Medicine (NEJM), in which the Hospital Clínic has participated, the combined treatment with BRAF and MEK inhibitors increases survival in patients with metastatic melanoma. Dr. Ana Arance, senior specialist at the Medical Oncology Department (ICMHO), is one of the authors.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Friday April 17th, 2009

New data on the breakdown of the KRas protein

D'esq. a dreta: el Dr. Carles Enrich, el Dr. Albert Lu i el Dr. Oriol Bachs.

KRas is one of the usual suspects in cancer. It is a protein that is mutated in 30% of human tumors and has been implicated in the regulation of many cell signalling pathways. For this reason, it is one of the main focuses of attention of international basic research and it is difficult to publish new information relating to its molecular biology. Researchers from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the University of Barcelona (UB) have discovered a new breakdown pathway for this protein. The results, which could mean a new form of signalling involving KRas, were published in the latest edition of the Journal of Cell Biology (184(6):863-79), where they merited an appearance on the front page of the journal and an editorial comment. This study is part of the doctoral thesis of Dr. Albert Lu and includes the participation of Dr. Oriol Bachs, Dr. Carles Enrich, Dr. Neus Agell and Dr. Francesc Tebar, researchers from IDIBAPS and the Department of Cell Biology, Immunology and Neuroscience of the Faculty of Medicine of the University of Barcelona. Researchers from the University of Kyoto also took part in the study.

Read the rest of this entry »

Comments Closed
Wednesday April 01st, 2009

Catalonia Joins the Fight Against Colon and Rectal Cancer

Last March 31th Hospital Clínic and Hospital del Mar did organize the workshop against colon and rectal cancer

On the occasion of Colon and Rectal Cancer (CRC) Prevention Day, held on 31 March throughout Spain, Hospital del Mar and Hospital Clínic de Barcelona jointly organized the Conference on Prevention of CRC in Catalonia, which took place at Hospital Clínic on the same day, with the presence of different people from many scientific, political and social organizations.

Read the rest of this entry »

Comments Closed
Tuesday February 24th, 2009

A New Technology Identifies Genes Implicated in the Development of Liver Cancer.

Dr. Augusto Villanueva i Dr. Josep Mª Llovet

This study, published in the journal Nature Biotechnology and led by Dr. Josep Maria Llovet of Hospital Clínic de  Barcelona – IDIBAPS together with researchers from the University of Minnesota (USA), describes for the first time a new technology for genetic manipulation in experimental animals for identifying therapeutic targets that facilitate the development of drugs that improve patient outcome.

Read the rest of this entry »

Comments Closed
Thursday January 22nd, 2009

The First Scientific Meeting of the IIS Clínic-IDIBAPS with the IRB Focuses on Cancer

The meeting was held at hotel HiltonThe Institute for Health Care Research (IIS) Clínic-IDIBAPS is a new body that was created as a result of the accreditation of our center by the Ministry of Science and Innovation. The first scientific  meeting under the umbrella of the strategic alliance, which joins the efforts of this new institute with those of the IRB, was held on 22 January. The theme of the meeting was  cancer and this allowed scientists from IDIBAPS-Clínic and the IRB to share experiences and approaches during an intense conference held at the Barcelona Hilton Hotel.

The aim of this initiative is to encourage the creation of networks of cooperation between the two institutions. New themed meetings of this type will be held over the coming months. The 3 planned themes are: Neurosciences; hepatic and metabolic diseases; and Infectious diseases, research on international health and immunology. It is necessary to continue to join forces to make the research done in Barcelona, Catalonia and Spain increasingly competitive at international level.

Comments Closed
Page 2 of 212